Overcoming Chemotherapy Resistance in Refractory Multiple Myeloma With Simvastatin, A Pilot Study
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 12 May 2017
At a glance
- Drugs Simvastatin (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 08 May 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 20 Feb 2017 Planned initiation date changed from 1 Nov 2016 to 1 Apr 2017.
- 25 Nov 2016 New trial record